Send to:

Choose Destination
See comment in PubMed Commons below
Expert Rev Vaccines. 2009 Oct;8(10):1351-64. doi: 10.1586/erv.09.78.

Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.

Author information

  • 1Children's Hospital, Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany.


In 2000/2001, a 7-valent pneumococcal conjugate vaccine (PCV-7) was licensed in Europe. During the following years and based on positive experiences from the USA, more and more European countries recommended routine immunization of infants and of children at an increased risk for invasive pneumococcal disease. Many studies documented the impact on invasive pneumococcal disease, but also on noninvasive pneumococcal disease. This review summarizes current evidence on the population-based impact of infant immunization programs in Europe.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Write to the Help Desk